ABSTRACT Although tuberculosis is a recognised cause of adrenal insufficiency, little is known about adrenal function in patients with active tuberculosis. Ninety Melanesian adults with active tuberculosis (30 pulmonary, 30 miliary, 30 extrapulmonary) had adrenal function assessed prospectively before and three to four weeks after starting antituberculous chemotherapy. Basal serum cortisol concentrations were normal in 55 (61 %) and raised in 35 (39%) of the subjects. No patient had a low basal cortisol concentration. After Synacthen stimulation, cortisol responses were normal in 81 (92%) of the patients and subnormal in seven (8%). After antituberculous chemotherapy the response to Synacthen stimulation was normal in all but one patient. It is concluded that adrenal dysfunction is an uncommon problem in patients with active tuberculosis, and that, contrary to recent reports, antituberculous chemotherapy regimens that include rifampicin do not have an adverse effect on adrenal function.
Introduction
Tuberculosis is a recognised cause of adrenal failure. In a review of necropsy findings in 403 patients with Addison's disease from 1900 to 1929 tuberculosis of the adrenals is said to have been found in 69-7% of cases.' As the incidence of tuberculosis in developed countries has declined, its importance in the aetiology of Addison's disease has diminished.2' Far less is known, however, about adrenal function in patients with active tuberculosis nor is it known whether adrenal function varies in these patients according to the extent of their disease.
We sought therefore to determine the state of adrenal function in a prospective study of patients with active tuberculosis. The effects of disease extent and antituberculous chemotherapy were investigated. On entry into the study all patients had the following investigations: (1) serum sodium (Na+) and potassium (K+) concentrations; (2) basal serum cortisol concentration, measured at 7.30 and 8.00 am (the basal concentration was taken as the mean of these Adrenalfunction in patients with active tuberculosis two measurements); (3) a standard Synacthen stimulation test.8 After the intravenous injection of 0-25 mg Synacthen (synthetic adrenocorticotrophic hormone) at 8.00 am, serial serum samples for measurement of cortisol concentration were collected at 30 minute intervals for two hours.
Antituberculous chemotherapy was then started, which consisted of the four drug regimen isoniazid, rifampicin, streptomycin, and pyrazinamide. Measurements of basal serum cortisol concentration and a Synacthen stimulation test were repeated 20-30 days after the start of treatment.
The mean serum sodium and potassium concentrations for each group of patients were compared by a one way analysis of variance.
Results

SERUM ELECTROLYTES
The serum Na+ concentration was normal (135-145 mmol/l) in 53 and below normal in 37 patients. Most cases of hyponatraemia were mild, the lowest value being 124 mmol/l. There was no significant difference between the three groups with respect to the prevalence of hyponatraemia. Serum K+ concentration was normal (3 5-4-9 mmol/l) in 63 and below normal in 27 patients. None Seventy seven patients were restudied 20-30 days after starting antituberculous chemotherapy. The remaining 13 patients were not restudied owing to transfer to another health centre (5), self discharge from hospital (5), or death (3). Of the 77 patients restudied, only five had persistently raised basal serum cortisol concentrations; the remainder had concentrations within the normal range. All three groups had lower mean basal serum concentrations than before treatment (table 2) . After Synacthen stimulation all subjects had a normal cortisol response except for one subject, whose increment in serum cortisol was 120 nmol/l.
Discussion
There is evidence that secretion of the major corticosteroid hormones is stimulated early in the course of acute infectious illness.W" In contrast, adrenocorticol secretion is generally depressed during chronic infections, including tuberculosis. 12-4 Few published studies have examined adrenal function in patients with active tuberculosis. A recent report from South Africa'5 described a suboptimal response to Synacthen in 55% of African Zulus with acute pulmonary tuberculosis. In these patients antituberculous chemotherapy had a favourable effect on adrenal function, though those who received rifampicin showed less improvement than those who were given regimens that did not include rifampicin. It was postulated that rifampicin, by its effect on hepatic enzyme induction and subsequent increased glucocorticoid metabolism, may disturb adrenal function.'617 Our study, however, showed that a regimen that included rifampicin for all patients had a 424 favourable effect on adrenal function, only one of 76 patients having a subnormal Synacthen response three to four weeks after starting treatment. The striking difference in results between our study and the African study may be explained by differences in the criteria used to assess abnormal adrenal function. In the study from Africa basal serum cortisol concentrations are not reported, the response to Synacthen was based on only one serum specimen taken one hour after Synacthen injection, and a normal cortisol response was defined as a rise of at least 300 nmol/l above the baseline value.
Serum Na+ concentration was a poor predictor of adrenal function in our study. '4 We conclude that there is a low but definite incidence of adrenal dysfunction in patients with active tuberculosis. Antituberculous chemotherapy Barnes, Naraqi, Temu, Turtle regimens that include rifampicin have a favourable effect on adrenal function.
